Advertisement

Topics

Dendritic NanoTechnologies Inc Company Profile

02:33 EDT 26th September 2018 | BioPortfolio

Dendritic NanoTechnologies Inc. (DNT) is the world’s leading developer and provider of advanced dendritic polymers. DNT has breakthrough technology that provides the vehicle — the targeting and delivery mechanisms — for a vast array of diagnostics and therapeutics currently in development in the biotechnology and pharmaceutical industries.DNT is a U.S. company incorporated in 2003 and located in Mount Pleasant, Michigan on the campus of Central Michigan University (CMU). DNT is developing and commercializing dendrimers — a type of polymer. These new types of nanostructures (particles so small they allow us to build new structures, literally, atom-by-atom) hold great promise for real-world applications, such as biotechnology and pharmaceuticals. DNT's business strategies are based on a broad technology platform advanced by DNT's founder, Donald A. Tomalia, Ph.D. from his initial discovery of dendrimers in 1979.

Location

2625 Denison Drive
Mount Pleasant
Michigan
48858
United States of America

Contact

Phone: (989) 774-4199
Fax: (989) 774-2322
Email: info@dnanotech.com


News Articles [52 Associated News Articles listed on BioPortfolio]

Dendritic Vaccine for Glioblastoma: Hope Hyped, Say Some

Survival for patients with newly diagnosed glioblastoma may be given a boost if initial results of dendritic vaccines using patients' own cells hold up. But experts are skeptical. Medscape Medical...

17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM

17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM   FEATURED SPEAKERS AND PANELISTS   Noubar Afeyan, PhD Founder ...

SYNOPSIS – 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM

SYNOPSIS – 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM     https://kochinstituteevents.cvent.com/...

Applying Nanotechnologies for Immunotherapy

Nanotechnological strategies are making preclinical strides toward more effective, less toxic, immunotherapies.

SOTIO's Dendritic Cell Vaccines Have Promise In Ovary And Lung Cancer

Interim Phase II data has shown that SOTIO's dendritic cell-based cancer vaccine candidates have efficacy in patients with ovarian cancer...  

A Reimagined Future for Sustainable Nanomaterials

NewsYale-led study may pave the way for sustainable nanotechnologies.Contributed Author: University Of Pi

New software designed for rapid, automated identification of dendritic spines

(Max Planck Florida Institute for Neuroscience) Researchers at the Max Planck Florida Institute for Neuroscience release open source software, connecting and building the neuroscience coding community...

Original Tweets Re-Tweets and Likes by @pharma_BI and @AVIVA1950 at #kisymposium for 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM

Original Tweets Re-Tweets and Likes by @pharma_BI and @AVIVA1950 at #kisymposium for 17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15,...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Viroptic [Monarch Pharmaceuticals, Inc]

VIROPTIC Ophthalmic Solution, 1% Sterile(trifluridine ophthalmic solution)

Zirgan [Bausch & Lomb Incorporated]

These highlights do not include all the information needed to use ZIRGAN safely and effectively. See full prescribing information for ZIRGAN.ZIRGAN (ganciclovir ophthalmic gel) 0.15%Initial U.S. Appro...

Trifluridine [Falcon Pharmaceuticals, Ltd.]

TRIFLURIDINE OPHTHALMIC SOLUTION, 1%

Statrol®neomycin and polymyxin bsulfates ophthalmic ointment, usp [ALCON LABORATORIES, INC.]

Statrol®neomycin and polymyxin Bsulfates ophthalmic ointment, USP

Statrol®neomycin and polymyxin bsulfates ophthalmic solution, usp [Alcon]

Statrol®neomycin and polymyxin Bsulfates ophthalmic solution, USP

PubMed Articles [335 Associated PubMed Articles listed on BioPortfolio]

Glutathione: Antioxidant Properties Dedicated to Nanotechnologies.

Which scientist has never heard of glutathione (GSH)? This well-known low-molecular-weight tripeptide is perhaps the most famous natural antioxidant. However, the interest in GSH should not be restric...

Nanotechnologies for site specific drug delivery: changing the narrative.

This account of issues in the field of nanotechnologies for specific drug delivery is concerned mainly with its diverse literature. It is a prelude to proposing guidelines to ensure that papers are wr...

Automated dendritic spine detection using convolutional neural networks on maximum intensity projected microscopic volumes.

Dendritic spines are structural correlates of excitatory synapses in the brain. Their density and structure are shaped by experience, pointing to their role in memory encoding. Dendritic spine imaging...

3D morphology-based clustering and simulation of human pyramidal cell dendritic spines.

The dendritic spines of pyramidal neurons are the targets of most excitatory synapses in the cerebral cortex. They have a wide variety of morphologies, and their morphology appears to be critical from...

Regulatory dendritic cells: profiling, targeting, and therapeutic application.

There is currently increased focus on improved understanding of how dendritic cell tolerogenicity is determined and maintained, and on their therapeutic potential. We review recent progress in profili...

Clinical Trials [330 Associated Clinical Trials listed on BioPortfolio]

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

This research is being determine whether vaccinations with your own immune cells called " dendritic cells " can activate your immune system to fight your brain tumor.

Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer

The purpose of this study is to assess the safety and activity of DC/PC3, a dendritic cell vaccine used as immunotherapy for prostate cancer. The vaccine is made with each participants' o...

Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy

Open, randomized study of a trivalent dendritic cell therapy compared to standard therapy in primary treated patients with IDH wild-type, MGMT-promotor methylated glioblastoma. The IMP is ...

A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3

To define the safety and efficacy of sibling-supplied, HIV antigen-pulsed dendritic cells in increasing the immune response in HIV-infected patients. Dendritic cells are a type of white b...

Alpha-Type 1 Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer

Dendritic cells or "DCs" are special white blood cells that stimulate the immune system. This study is being done to test the feasibility, safety and efficacy of a specific type of dendrit...

Companies [30 Associated Companies listed on BioPortfolio]

Dendritic NanoTechnologies Inc

Dendritic NanoTechnologies Inc. (DNT) is the world’s leading developer and provider of advanced dendritic polymers. DNT has breakthrough technology that provides the vehicle — the targeting and de...

BioTime, Inc. and Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics, Inc. is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry leading platforms are ba...

DCPrime

DCPrime develops off-the-shelf dendritic cell-based vaccines for a broad range of cancer types, based on its unique, proprietary technology platform, DCOne™. DCOne-based dend...

MagForce Nanotechnologies AG

MagForce Nanotechnologies AG is a world-leading company in the area of nanotechnology-based cancer treatment. Its patented Nano-Cancer® therapy enables the targeted destruction...

The Project on Emerging Nanotechnologies

More Information about "Dendritic NanoTechnologies Inc" on BioPortfolio

We have published hundreds of Dendritic NanoTechnologies Inc news stories on BioPortfolio along with dozens of Dendritic NanoTechnologies Inc Clinical Trials and PubMed Articles about Dendritic NanoTechnologies Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dendritic NanoTechnologies Inc Companies in our database. You can also find out about relevant Dendritic NanoTechnologies Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record